Sun Pharma arm receives DCGI approval for Molnupiravir in India
Synopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
Synopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
Summary : -Royal Philips, a global leader in health technology, announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle…
Synopsis: Consultant uro-oncologist and robotic surgeon Abhay Kumar of Medica Superspecialty Hospital (MSH) said this robot-assisted surgery allowed a surgeon to go…
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…
Summary – The European Medicines Agency (EMA) has issued a list of about 100 regulatory science topics that need further research to close…
Synopsis- Under the extended contract, the dedicated R&D center, ‘Syngene Amgen Research and Development Center’ (SARC), will continue to conduct drug discovery…
Summary – Lupin Diagnostics, a 100 percent subsidiary of Lupin Limited, has set up a state-of-the-art 45,000 sq. ft National Reference Laboratory…
SYNOPSIS: New 510(k) clearance expands the use of MammoScreen from 2D to 3D mammography, opening up the entire breast cancer screening market.…
SUMMARY: The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive…
KEYPOINTS Sun Pharmaceutical Industries is getting set to bring out its version of molnupiravir, the anti-viral drug from Merck Sharpe Dohme and…